Company intelligence / Profile preview
Astion Pharma
Vissenbjerg, Syddanmark, Denmarkastionpharma.com ↗
- Ownership
- Private
- Development stage
- Commercial
01
Overview
Astion Pharma has developed commercial products for eczema treatment. Historically, they had drug candidates including ASF-1096 for cutaneous lupus erythematosus which completed Phase I with favorable results and was advancing to Phase III, and ASF-1057 for seborrheic dermatitis which was in Phase II studies in France and the UK[3].
- Therapeutic areas
- ImmunologyDermatology
- Modalities
- Topical creamspharmaceutical products
- Industry
- Biotech
02
Drug pipeline
4 assets3 more assets in the full pipeline.
Beyond the preview
Go deeper on Astion Pharma.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Astion Pharma.